Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 17.75
+0.16 (0.91%)
Last updated: Apr 17, 2026, 1:10 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 7.36 billion as of April 16, 2026. Its market cap has increased by 48.95% in one year.
Market Cap
7.36B
Enterprise Value
6.09B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.75
Market Cap Chart
Since June 29, 2023, Laekna's market cap has increased from 5.85B to 7.36B, an increase of 25.73%. That is a compound annual growth rate of 8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 7.36B | 29.62% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alphamab Oncology | 10.85B |
| Lepu Biopharma | 10.48B |
| Guangzhou Innogen Pharmaceutical Group | 9.42B |
| Shanghai Haohai Biological Technology | 9.26B |
| Abbisko Cayman | 8.83B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Ocumension Therapeutics | 6.45B |
| Jacobio Pharmaceuticals Group | 6.00B |